{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:44:22Z","timestamp":1776818662275,"version":"3.51.2"},"reference-count":81,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The purpose of this review is to summarize and apply existing literature to acute and chronic pain management for patients using buprenorphine for opioid use disorder (OUD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Pain management in patients taking buprenorphine for OUD presents many challenges for clinicians. Buprenorphine has unique pharmacological properties compared to full \u03bc-opioid receptor agonists, including a strong affinity for and slow dissociation from the \u03bc opioid receptor. Patients using buprenorphine have more pain than those not utilizing chronic opioid therapy, as occurs with most chronic opioid use. This may be due to the development of tolerance or hyperalgesia or may be part of the OUD process. Management of chronic pain should be approached the same as with any patient, focusing on nonpharmacological and nonopioid therapies, as opioid therapies have been shown to have very little efficacy for chronic pain. Management of acute pain is based on maintaining a stable dose of buprenorphine and supplementing with full \u03bc-opioid receptor agonists, nonopioid analgesics, and nonpharmacological therapies. Transitioning to buprenorphine, in either the inpatient or outpatient setting, can be done with standard, low-dose, or high-dose induction based on the clinical situation. Transitions to and from the acute care setting require extensive communication and are enhanced by multidisciplinary teams.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>It is imperative that providers be knowledgeable about buprenorphine and how to optimize it for OUD as well as pain. Pain management with buprenorphine can be tailored to the patient and clinical situation, but any therapeutic plan must contain a holistic approach and involve extensive communication that includes the patient and all relevant providers to achieve safe and effective care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaf293","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:19:56Z","timestamp":1761743996000},"page":"e317-e326","source":"Crossref","is-referenced-by-count":0,"title":["The role of buprenorphine in patients with opioid use disorder in need of acute or chronic pain management"],"prefix":"10.1093","volume":"83","author":[{"given":"Tanya J","family":"Uritsky","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Hospital of the University of Pennsylvania , Philadelphia, PA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin A","family":"Miskle","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, The University of Iowa Carver College of Medicine and University of Iowa College of Pharmacy , Iowa City, IA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee A","family":"Kral","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, The University of Iowa Carver College of Medicine , Iowa City, IA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"2026042119563553600_zxaf293-B1","doi-asserted-by":"crossref","first-page":"100052","DOI":"10.1016\/j.dadr.2022.100052","article-title":"What is the prevalence of and trend in opioid use disorder in the United States from 2010-2019? Using multiplier approaches to estimate prevalence for an unknown population size","volume":"3","author":"Keyes","year":"2022","journal-title":"Drug Alcohol Depend Rep"},{"key":"2026042119563553600_zxaf293-B2","volume-title":"Package insert","author":"Buprenex","year":"2019"},{"key":"2026042119563553600_zxaf293-B3","author":"Subutex","year":"2025","journal-title":"Package insert"},{"key":"2026042119563553600_zxaf293-B4","author":"Suboxone","year":"2025","journal-title":"Package insert"},{"key":"2026042119563553600_zxaf293-B5","author":"Zubsolv","year":"2025","journal-title":"Package insert"},{"key":"2026042119563553600_zxaf293-B6","author":"Sublocade","year":"2025","journal-title":"Package insert"},{"key":"2026042119563553600_zxaf293-B7","author":"Brixadi","year":"2023","journal-title":"Package insert"},{"issue":"3","key":"2026042119563553600_zxaf293-B8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.drugalcdep.2011.10.027","article-title":"\u03bc-Opioid receptors and regulators of G protein signaling (RGS) proteins: from a symposium on new concepts in \u03bc opioid pharmacology","volume":"121","author":"Traynor","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"2026042119563553600_zxaf293-B9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/bja\/ael051","article-title":"Buprenorphine induces ceiling in respiratory depression but not in analgesia","volume":"96","author":"Dahan","year":"2006","journal-title":"Br J Anaesth"},{"issue":"3","key":"2026042119563553600_zxaf293-B10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0952-8180(91)90158-J","article-title":"Postoperative pain management and respiratory depression after thoracotomy: a comparison of intramuscular piritramide and intravenous patient-controlled analgesia using fentanyl or buprenorphine","volume":"3","author":"Lehmann","year":"1991","journal-title":"J Clin Anesth"},{"issue":"1","key":"2026042119563553600_zxaf293-B11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/60.1.48","article-title":"Double-blind, multiple-dose comparison of buprenorphine and morphine in postoperative pain of children","volume":"60","author":"Maunuksela","year":"1988","journal-title":"Br J Anaesth"},{"issue":"5","key":"2026042119563553600_zxaf293-B12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2044.1979.tb06325.x","article-title":"Analgesic effects of sublingual buprenorphine","volume":"34","author":"Edge","year":"1979","journal-title":"Anaesthesia"},{"issue":"6","key":"2026042119563553600_zxaf293-B13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1399-6576.1980.tb01584.x","article-title":"Double-blind, multiple-dose comparison of buprenorphine and morphine in postoperative pain","volume":"24","author":"Tigerstedt","year":"1980","journal-title":"Acta Anaesthesiol Scand"},{"issue":"11","key":"2026042119563553600_zxaf293-B14","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1365-2044.1987.tb05222.x","article-title":"Epidural sufentanil versus intramuscular buprenorphine for postoperative analgesia. A double-blind comparative trial","volume":"42","author":"Donadoni","year":"1987","journal-title":"Anaesthesia"},{"issue":"7","key":"2026042119563553600_zxaf293-B15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5055\/jom.2021.0639","article-title":"Emerging pharmacologic mechanisms of buprenorphine to explain experience of analgesia versus adverse effects","volume":"17","author":"Bettinger","year":"2021","journal-title":"J Opioid Manag"},{"issue":"2","key":"2026042119563553600_zxaf293-B16","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3565(24)29586-0","article-title":"Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist","volume":"297","author":"Huang","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"18","key":"2026042119563553600_zxaf293-B17","doi-asserted-by":"crossref","first-page":"7074","DOI":"10.1523\/JNEUROSCI.20-18-07074.2000","article-title":"Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance","volume":"20","author":"Vanderah","year":"2000","journal-title":"J Neurosci"},{"issue":"15","key":"2026042119563553600_zxaf293-B18","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1523\/JNEUROSCI.22-15-06747.2002","article-title":"Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers","volume":"22","author":"Gardell","year":"2002","journal-title":"J Neurosci"},{"issue":"2","key":"2026042119563553600_zxaf293-B19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.36076\/ppj.2011\/14\/145","article-title":"A comprehensive review of opioid induced hyperalgesia","volume":"14","author":"Lee","year":"2011","journal-title":"Pain Physician"},{"issue":"3","key":"2026042119563553600_zxaf293-B20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.yrtph.2010.12.007","article-title":"Uniform assessment and ranking of opioid \u03bc receptor binding constants for selected opioid drugs","volume":"59","author":"Volpe","year":"2011","journal-title":"Regul Toxicol Pharmacol."},{"key":"2026042119563553600_zxaf293-B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.07.035","article-title":"Buprenorphine maintenance and \u03bc-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy","volume":"144","author":"Greenwald","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"2026042119563553600_zxaf293-B22","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s00213-005-0023-6","article-title":"Buprenorphine\/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers","volume":"181","author":"Comer","year":"2005","journal-title":"Psychopharmacol"},{"issue":"1","key":"2026042119563553600_zxaf293-B23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopsych.2006.04.043","article-title":"Buprenorphine duration of action: \u03bc-opioid receptor availability and pharmacokinetic and behavioral indices","volume":"61","author":"Greenwald","year":"2007","journal-title":"Biol Psychiatry."},{"issue":"3","key":"2026042119563553600_zxaf293-B24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0033-3182(10)70693-9","article-title":"Characteristics of pain patients with opioid-use disorder","volume":"51","author":"Haller","year":"2010","journal-title":"Psychosomatics"},{"issue":"5","key":"2026042119563553600_zxaf293-B25","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0310057X1103900505","article-title":"Acute pain management in opioid-tolerant patients: a growing challenge","volume":"39","author":"Huxtable","year":"2011","journal-title":"Anaesth Intensive Care"},{"key":"2026042119563553600_zxaf293-B26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.drugalcdep.2015.02.007","article-title":"Longitudinal analysis of pain and illicit drug use behaviors in outpatients on methadone maintenance","volume":"149","author":"Dhingra","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"2026042119563553600_zxaf293-B27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1185\/03007995.2015.1016607","article-title":"Sources of prescription opioids among diagnosed opioid abusers","volume":"31","author":"Shei","year":"2015","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"2026042119563553600_zxaf293-B28","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0025-7125(05)70133-4","article-title":"Opioid use in the management of chronic pain","volume":"83","author":"Savage","year":"1999","journal-title":"Med Clin North Am"},{"issue":"6","key":"2026042119563553600_zxaf293-B29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1360-0443.1990.tb01693.x","article-title":"Fallacies and phobias about addiction and pain","volume":"85","author":"Lander","year":"1990","journal-title":"Br J Addict"},{"key":"2026042119563553600_zxaf293-B30","doi-asserted-by":"crossref","first-page":"108343","DOI":"10.1016\/j.drugalcdep.2020.108343","article-title":"Risk of discharge against medical advice among hospital inpatients with a history of opioid agonist therapy in New South Wales, Australia: a cohort study and nested crossover-cohort analysis","volume":"217","author":"Lewer","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"2026042119563553600_zxaf293-B31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0376-8716(80)90455-X","article-title":"A study of hospitalized surgical patients on methadone maintenance","volume":"6","author":"Kantor","year":"1980","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"2026042119563553600_zxaf293-B32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-144-2-200601170-00010","article-title":"Acute pain management for patients receiving maintenance methadone or buprenorphine therapy","volume":"144","author":"Alford","year":"2006","journal-title":"Ann Intern Med"},{"issue":"5","key":"2026042119563553600_zxaf293-B33","first-page":"327","article-title":"Mutual mistrust in the medical care of drug users: the keys to the \u201cnarc\u201d cabinet","volume":"17","author":"Merrill","year":"2002","journal-title":"J Gen Intern Med"},{"key":"2026042119563553600_zxaf293-B34","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2147\/JPR.S102090","article-title":"The American chronic pain crisis and the media: about time to get it right?","volume":"8","author":"Schatman","year":"2015","journal-title":"J Pain Res"},{"issue":"3","key":"2026042119563553600_zxaf293-B35","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.mayocp.2017.12.020","article-title":"How good intentions contributed to bad outcomes: the opioid crisis","volume":"93","author":"Rummans","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"2026042119563553600_zxaf293-B36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13011-022-00480-4","article-title":"The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis","volume":"17","author":"Dickson-Gomez","year":"2022","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"2026042119563553600_zxaf293-B37","author":"National Institute of Drug Abuse. US overdose deaths, select drugs or drug categories","year":"1999-2023"},{"issue":"2","key":"2026042119563553600_zxaf293-B38","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/art.41142","article-title":"American College of Rheumatology\/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip and knee","volume":"72","author":"Kolasinski","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"2026042119563553600_zxaf293-B39","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12891-024-07468-0","article-title":"Recent clinical practice guidelines for the management of low back pain: a global comparison","volume":"25","author":"Zhou","year":"2024","journal-title":"BMX Musculoskelet Disord"},{"issue":"1","key":"2026042119563553600_zxaf293-B40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jamainternmed.2019.4917","article-title":"Mind-body therapies for opioid-treated pain: a systematic review and meta-analysis","volume":"180","author":"Garland","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"5","key":"2026042119563553600_zxaf293-B41","first-page":"401","article-title":"Opioids no better than placebo at relieving back pain","volume":"330","author":"Harris","year":"2023","journal-title":"JAMA"},{"issue":"5","key":"2026042119563553600_zxaf293-B42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(25)00068-7","article-title":"Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis","volume":"24","author":"Soliman","year":"2025","journal-title":"Lancet Neurol"},{"key":"2026042119563553600_zxaf293-B43","author":"International Association for the Study of Pain"},{"key":"2026042119563553600_zxaf293-B44","author":"Agency for Healthcare Research and Quality"},{"issue":"10","key":"2026042119563553600_zxaf293-B45","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4088\/JCP.15m09963","article-title":"Psychiatric disorders among patients seeking treatment for co-occurring chronic pain and opioid use disorder","volume":"77","author":"Barry","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"2026042119563553600_zxaf293-B46","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jseint.2022.06.001","article-title":"Application of risk assessment tools to predict opioid usage after shoulder surgery","volume":"6","author":"Khoury","year":"2022","journal-title":"JSES Int"},{"issue":"5","key":"2026042119563553600_zxaf293-B47","doi-asserted-by":"crossref","first-page":"e193365","DOI":"10.1001\/jamanetworkopen.2019.3365","article-title":"Strategies to identify patient risks of prescription opioid addiction when initiating opioids for pain: a systematic review","volume":"2","author":"Klimas","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"8","key":"2026042119563553600_zxaf293-B48","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.pain.2013.05.004","article-title":"Buprenorphine\/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone","volume":"154","author":"Roux","year":"2013","journal-title":"Pain"},{"issue":"12","key":"2026042119563553600_zxaf293-B49","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1093\/pm\/pnaa089","article-title":"Is buprenorphine effective for chronic pain? A systematic review and meta-analysis","volume":"21","author":"Lazaridou","year":"2020","journal-title":"Pain Med"},{"issue":"10","key":"2026042119563553600_zxaf293-B50","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/rapm-2021-103007","article-title":"Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel","volume":"46","author":"Kohan","year":"2021","journal-title":"Reg Anesth Pain Med"},{"key":"2026042119563553600_zxaf293-B51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40140-024-00612-5","article-title":"Perioperative management of patients on buprenorphine: a literature review","volume":"14","author":"Furtado-Pessoa-de-Mendonca","year":"2024","journal-title":"Curr Anesth Rep"},{"issue":"12","key":"2026042119563553600_zxaf293-B52","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1007\/s11606-020-06115-3","article-title":"Treating perioperative and acute pain in patients on buprenorphine: narrative literature review and practice recommendations","volume":"35","author":"Buresh","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"3","key":"2026042119563553600_zxaf293-B53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.anclin.2018.04.002","article-title":"Perioperative considerations for the patient with opioid use disorder on buprenorphine, methadone, or naltrexone maintenance therapy","volume":"36","author":"Harrison","year":"2018","journal-title":"Anesthesiol Clin"},{"issue":"12","key":"2026042119563553600_zxaf293-B54","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1302\/2058-5241.6.210045","article-title":"A guide to regional analgesia for total knee arthroplasty","volume":"6","author":"Rodriguez-Patarroyo","year":"2021","journal-title":"EFORT Open Rev"},{"key":"2026042119563553600_zxaf293-B55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijsu.2019.08.026","article-title":"Ketamine reduces pain and opioid consumption after total knee arthroplasty: a meta-analysis of randomized controlled studies","volume":"70","author":"Li","year":"2019","journal-title":"Int J Surg"},{"issue":"1","key":"2026042119563553600_zxaf293-B56","first-page":"59","article-title":"Pharmacologic methods for preventing pruritus in patients receiving intrathecal opioids for cesarean delivery","volume":"86","author":"Vice-O\u2019Con","year":"2018","journal-title":"AANA J"},{"issue":"3","key":"2026042119563553600_zxaf293-B57","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0970-9185.117045","article-title":"Neuraxial opioid-induced pruritus: an update","volume":"29","author":"Kumar","year":"2013","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"2026042119563553600_zxaf293-B58","author":"Food and Drug Administration"},{"issue":"1","key":"2026042119563553600_zxaf293-B59","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pmn.2019.08.003","article-title":"Managing pain in the setting of opioid use disorder","volume":"21","author":"St. Marie","year":"2020","journal-title":"Pain Manag Nurs"},{"key":"2026042119563553600_zxaf293-B60","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2147\/PPA.S252670","article-title":"Patients\u2019 experience and needs during perioperative care: a focus group study","volume":"14","author":"Gobbo","year":"2020","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"2026042119563553600_zxaf293-B61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12954-021-00581-6","article-title":"Acute pain and self-directed discharge among hospitalized patients with opioid-related diagnoses: a cohort study","volume":"18","author":"Compton","year":"2021","journal-title":"Harm Reduct J"},{"issue":"2","key":"2026042119563553600_zxaf293-B62","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/29767342241231114","article-title":"Xylazine and adulterants in the evolving drug supply: urgent call for responsive education models","volume":"45","author":"Jawa","year":"2024","journal-title":"Subst Use Addctn J"},{"issue":"15","key":"2026042119563553600_zxaf293-B63","doi-asserted-by":"crossref","first-page":"269","DOI":"10.15585\/mmwr.mm7415a3","article-title":"Notes from the field: severe medetomidine withdrawal syndrome in patients using illegally manufactured opioids\u2014Pittsburgh, Pennsylvania, October 2024\u2013March 2025","volume":"74","author":"Ostrowski","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"4","key":"2026042119563553600_zxaf293-B64","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jhm.13238","article-title":"Point\/counterpoint: should full agonist opioid medications be offered to hospitalized patients for management of opioid withdrawal?","volume":"19","author":"Stern","year":"2024","journal-title":"J Hosp Med"},{"issue":"11","key":"2026042119563553600_zxaf293-B65","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/jhm.13138","article-title":"Things we do for no reason: avoiding methadone for opioid withdrawal","volume":"18","author":"Martin","year":"2023","journal-title":"J Hosp Med"},{"key":"2026042119563553600_zxaf293-B66","doi-asserted-by":"crossref","first-page":"1552084","DOI":"10.3389\/fpsyt.2025.1552084","article-title":"Ketamine in treating opioid use disorder and opioid withdrawal: a scoping review","volume":"16","author":"Shen","year":"2025","journal-title":"Front Psychiatry"},{"issue":"5","key":"2026042119563553600_zxaf293-B67","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/ADM.0000000000001189","article-title":"Evidence on buprenorphine dose limits: a review","volume":"17","author":"Grande","year":"2023","journal-title":"J Addict Med"},{"issue":"4","key":"2026042119563553600_zxaf293-B68","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jsat.2010.12.002","article-title":"A comparison of buprenorphine induction strategies: patient-centered home-based inductions versus standard-of-care office-based inductions","volume":"40","author":"Cunningham","year":"2011","journal-title":"J Subst Abuse Treat"},{"key":"2026042119563553600_zxaf293-B69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/SAR.S109919","article-title":"Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method","volume":"7","author":"H\u00e4mmig","year":"2016","journal-title":"Subst Abuse Rehabil"},{"issue":"7","key":"2026042119563553600_zxaf293-B70","doi-asserted-by":"crossref","first-page":"e2117128","DOI":"10.1001\/jamanetworkopen.2021.17128","article-title":"High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder","volume":"4","author":"Herring","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2S suppl 1","key":"2026042119563553600_zxaf293-B71","first-page":"1","article-title":"The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update","volume":"14","year":"2020","journal-title":"J Addict Med"},{"issue":"1","key":"2026042119563553600_zxaf293-B72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13011-016-0085-y","article-title":"Systemic and individual factors in the buprenorphine treatment-seeking process: a qualitative study","volume":"12","author":"Hewell","year":"2017","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"4","key":"2026042119563553600_zxaf293-B73","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/ajad.12869","article-title":"Rapid micro-induction of buprenorphine\/naloxone for opioid use disorder in an inpatient setting: a case series","volume":"28","author":"Klaire","year":"2019","journal-title":"Am J Addict"},{"issue":"11","key":"2026042119563553600_zxaf293-B74","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.npp.1300251","article-title":"Effects of buprenorphine maintenance dose on \u03bc-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers","volume":"28","author":"Greenwald","year":"2003","journal-title":"Neuropsychopharmacology."},{"issue":"2","key":"2026042119563553600_zxaf293-B75","doi-asserted-by":"crossref","first-page":"e12408","DOI":"10.1002\/emp2.12408","article-title":"Improving transitions of care for patients initiated on buprenorphine for opioid use disorder from the emergency departments in King County, Washington","volume":"2","author":"Fockele","year":"2021","journal-title":"J Am Coll Emerg Physicians Open"},{"issue":"8","key":"2026042119563553600_zxaf293-B76","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s11606-020-05815-0","article-title":"Opioid agonist therapy during hospitalization within the Veterans Health Administration: a pragmatic retrospective cohort analysis","volume":"35","author":"Priest","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"5","key":"2026042119563553600_zxaf293-B77","doi-asserted-by":"crossref","first-page":"e205852","DOI":"10.1001\/jamanetworkopen.2020.5852","article-title":"Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients","volume":"3","author":"Kilaru","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"15","key":"2026042119563553600_zxaf293-B78","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1007\/s11606-024-08837-0","article-title":"Addiction consult service and inpatient outcomes among patients with OUD","volume":"39","author":"Jakubowski","year":"2024","journal-title":"J Gen Intern Med"},{"issue":"14","key":"2026042119563553600_zxaf293-B79","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1007\/s11606-023-08202-7","article-title":"Addiction consult service and inpatient outcomes among patients with alcohol use disorder","volume":"38","author":"Singh-Tan","year":"2023","journal-title":"J Gen Intern Med"},{"issue":"4","key":"2026042119563553600_zxaf293-B80","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.pcl.2019.03.004","article-title":"Communication at transitions of care","volume":"66","author":"Patel","year":"2019","journal-title":"Pediatr Clin North Am"},{"key":"2026042119563553600_zxaf293-B81","author":"Bajorek"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxaf293\/65039037\/zxaf293.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/9\/e317\/65039037\/zxaf293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/9\/e317\/65039037\/zxaf293.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:56:54Z","timestamp":1776815814000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/83\/9\/e317\/8306536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":81,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,10,30]]},"published-print":{"date-parts":[[2026,4,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaf293","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,1]]},"published":{"date-parts":[[2025,10,30]]}}}